Jazz Pharmaceuticals plc: Canaccord Genuity raises target price to $300 from $290
JAZZ•Related News
Gentex Q2 FY26 GAAP EPS rises to $0.54; net sales hit $651.3 million
GNTX•
Nasdaq Trade Halt <INTJ.O> Volatility Trading Pause at 10:14 AM
INTJ•
New Jersey AG files antitrust lawsuit against Amazon
AMZN•
US sees progress in Hormuz Strait talks, hopes for deal very shortly, Rubio says
XLE•
TransDigm jumps after raising FY profit, revenue forecast
TDG•